Integra LifeSciences (Integra) was founded in 1989 based on a vision to expand access to promising technology that enables the body to regenerate damaged or diseased tissue. Grounded on this vision, the company revolutionized the field of regenerative medicine and has since grown to be a leading global provider of neurosurgical solutions, regenerative technologies, and surgical instrumentation.
Integra now has a broad portfolio of products and solutions used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus, hemorrhagic stroke, and other neurological conditions. Our regenerative tissue technologies include products that address soft tissue, peripheral nerve and tendon repairs and are used for the treatment of acute and chronic wounds, burns, as well as for plastic and reconstructive surgery.
In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Integra is headquartered in Princeton, New Jersey and has over 3,500 employees worldwide. Integra's common stock is listed on The NASDAQ Stock Market under the symbol "IART."